Evans Capital
Contributor since: 2012
MEI Pharma Should Be Trading At $4 Per Share Today
ADA-ES Waiting For The Squeeze
SGOCO Group: Firing On All Cylinders
Why China Housing & Land Development Should Be Trading Substantially Higher
Adventrx Pharmaceuticals: Why It Is Worth Over $5 Per Share
Dangdang: Accumulating Shares
First Hand Technology Fund: Suddenly A Value Play
Firsthand Technology Value Fund - Time To Cover Short Position
Dangdang: Buy Opportunity
Apple: A Chink In The Armor, Part II
Is Google Pulling A Three-Card Monte Trick?
Wizzard Software: Acquiring The Redbox Of China
Renren: A Double From Here?
Firsthand Technology Value Fund: Time To Take A Short Position
A REIT That Is Recovering And A 10% Yield To Prove It
Why I Think Dangdang Will Trade Over $750/Share In 5 Years
Clean Diesel Technologies: Global Emissions Regulations Driving Growth
The Chink In Apple's Armor
Comverge: Investing In The Smart Grid Of The Future
New Concept Energy: A Highly Undervalued Utica Shale Play